Skip to content
10-Q

Quarterly Report

CARDIOVASCULAR SYSTEMS, INC.

0001180145-22-000019

← back to feed
Filed
May 5, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · May 2, 2022 40.79M sh
Shares Diluted Q3 2022 · Mar 31, 2022 39.29M sh
Shares Diluted Q3 2022 · Mar 31, 2022 39.19M sh
Shares Diluted Q3 2022 · Mar 31, 2021 38.91M sh
Shares Diluted Q3 2022 · Mar 31, 2021 38.8M sh
Capex Q3 2022 · Mar 31, 2022 $3.22M
Capex Q3 2022 · Mar 31, 2021 $2.76M
Operating Cash Flow Q3 2022 · Mar 31, 2022 −$14.44M
Operating Cash Flow Q3 2022 · Mar 31, 2021 −$2.42M
Cash And Equivalents Q3 2022 · Mar 31, 2022 $66.95M
Cash And Equivalents Q3 2022 · Jun 30, 2021 $71.07M
Stockholders Equity Q3 2022 · Mar 31, 2022 $253.5M
Stockholders Equity Q3 2022 · Dec 31, 2021 $259.53M
Stockholders Equity Q3 2022 · Sep 30, 2021 $263.19M
Stockholders Equity Q3 2022 · Jun 30, 2021 $270.96M
Stockholders Equity Q3 2022 · Mar 31, 2021 $270.45M
Stockholders Equity Q3 2022 · Dec 31, 2020 $273.83M
Stockholders Equity Q3 2022 · Sep 30, 2020 $268.41M
Stockholders Equity Q3 2022 · Jun 30, 2020 $268.79M
Current Liabilities Q3 2022 · Mar 31, 2022 $46.42M
Current Liabilities Q3 2022 · Jun 30, 2021 $54.65M
Total Liabilities Q3 2022 · Mar 31, 2022 $70.49M
Total Liabilities Q3 2022 · Jun 30, 2021 $81.61M
Current Assets Q3 2022 · Mar 31, 2022 $245.31M
Current Assets Q3 2022 · Jun 30, 2021 $284.67M
Total Assets Q3 2022 · Mar 31, 2022 $323.99M
Total Assets Q3 2022 · Jun 30, 2021 $352.57M
Eps Diluted Q3 2022 · Mar 31, 2022 −$0.25
Eps Diluted Q3 2022 · Mar 31, 2022 −$0.70
Eps Diluted Q3 2022 · Mar 31, 2021 −$0.15
Eps Diluted Q3 2022 · Mar 31, 2021 −$0.21
Eps Basic Q3 2022 · Mar 31, 2022 −$0.25
Eps Basic Q3 2022 · Mar 31, 2022 −$0.70
Eps Basic Q3 2022 · Mar 31, 2021 −$0.15
Eps Basic Q3 2022 · Mar 31, 2021 −$0.21
Sga Expense Q3 2022 · Mar 31, 2022 $41.68M
Sga Expense Q3 2022 · Mar 31, 2022 $123.93M
Sga Expense Q3 2022 · Mar 31, 2021 $41.44M
Sga Expense Q3 2022 · Mar 31, 2021 $121.79M
Rd Expense Q3 2022 · Mar 31, 2022 $9.05M
Rd Expense Q3 2022 · Mar 31, 2022 $27.95M
Rd Expense Q3 2022 · Mar 31, 2021 $13.16M
Rd Expense Q3 2022 · Mar 31, 2021 $31.82M
Net Income Q3 2022 · Mar 31, 2022 −$9.66M
Net Income Q3 2022 · Mar 31, 2022 −$27.24M
Net Income Q3 2022 · Dec 31, 2021 −$8.97M
Net Income Q3 2022 · Sep 30, 2021 −$8.62M
Net Income Q3 2022 · Mar 31, 2021 −$6M
Net Income Q3 2022 · Mar 31, 2021 −$8.14M
Net Income Q3 2022 · Dec 31, 2020 −$56K
Net Income Q3 2022 · Sep 30, 2020 −$2.08M
Operating Income Q3 2022 · Mar 31, 2022 −$9.65M
Operating Income Q3 2022 · Mar 31, 2022 −$26.32M
Operating Income Q3 2022 · Mar 31, 2021 −$5.65M
Operating Income Q3 2022 · Mar 31, 2021 −$7.02M
Gross Profit Q3 2022 · Mar 31, 2022 $41.43M
Gross Profit Q3 2022 · Mar 31, 2022 $126.56M
Gross Profit Q3 2022 · Mar 31, 2021 $49.26M
Gross Profit Q3 2022 · Mar 31, 2021 $147.49M
Cost Of Revenue Q3 2022 · Mar 31, 2022 $14.79M
Cost Of Revenue Q3 2022 · Mar 31, 2022 $47.17M
Cost Of Revenue Q3 2022 · Mar 31, 2021 $14.01M
Cost Of Revenue Q3 2022 · Mar 31, 2021 $40.5M
Revenue Q3 2022 · Mar 31, 2022 $56.22M
Revenue Q3 2022 · Mar 31, 2022 $173.73M
Revenue Q3 2022 · Mar 31, 2021 $63.27M
Revenue Q3 2022 · Mar 31, 2021 $187.99M